Table 6:

EC50 values for mutant α4β2 nAChRs

MotivationMutantEC50m ACh) ± SEMHill coefficient ± SEM
WT-LS(α4[wt])3(β2[wt])283.4 ± 4.670.905 ± 0.03
WT-HS(α4[wt])2(β2[wt])30.924 ± 0.06560.924 ± 0.1
WT-α5α5[wt](α4[wt]β2[wt])20.409 ± 0.04181.06 ± 0.1
9´ residue(α4[L9´A])2(β2[wt])30.499 ± 0.0321.43 ± 0.1
9´ residue(α4[L9´S])2(β2[wt])30.0356 ± 0.001451.29 ± 0.06
9´ residue(α4[L9´I])2(β2[wt])3960. ± 5020.489 ± 0.03
9´ residue(α4[L9´T])2(β2[wt])30.282 ± 0.02331.28 ± 0.1
9´ residue(α4[L9´Q])2(β2[wt])30.530 ± 0.01361.284 ± 0.03
9´ residue(α4[L9´C])2(β2[wt])32.68 ± 0.3110.710 ± 0.1
9´ residueα4[L9´F])2(β2[wt])30.547 ± 0.02091.26 ± 0.05
9´ residue(α4[L9´W])2(β2[wt])30.240 ± 0.009061.19 ± 0.05
GABA(α4[L376W])3(β2[wt])2247 ± 99.40.772 ± 0.1
MD(α4[V356A])3(β2[wt])2244 ± 1130.843 ± 0.2
GABA(α4[wt])3(β2[M305W])2180. ± 38.20.938 ± 0.1
MD(α4[wt])3(β2[W355L])2171 ± 28.01.04 ± 0.1
MD(α4[W363L])3(β2[wt])2159 ± 55.20.941 ± 0.2
GABA(α4[wt])3(β2[G364L])2153 ± 1640.728 ± 0.3
TRPM8(α4[L383A])3(β2[wt])2150. ± 7.670.919 ± 0.03
TRPM8(α4[wt])3(β2[R299A])2140. ± 64.70.510 ± 0.05
MD(α4[I357A])3(β2[wt])2124 ± 19.10.957 ± 0.09
MD(α4[W363L])3(β2[W355L])2122 ± 11.61.31 ± 0.1
GABA(α4[wt])3(β2[F306W])2106 ± 12.21.07 ± 0.1
ADNFLE(α4[S6'F])3(β2[wt])2105 ± 47.51.27 ± 0.1
MD(α4[F299A])3(β2[wt])283.2 ± 7.351.22 ± 0.1
9´ residue(α4[L9´O-Me-Thr])3(β2[wt])261.3 ± 4.641.07 ± 0.07
GABA(α4[wt])3(β2[L282W])277.5 ± 6.441.01 ± 0.06
GABA(α4[wt])3(β2[V360W])271.2 ± 5.791.24 ± 0.1
GABA(α4[M288W])3(β2[wt])270.8 ± 11.10.913 ± 0.1
GABA(α4[wt])3(β2[M280W])257.8 ± 6.941.29 ± 0.2
ADNFLE(α4[wt])3(β2[V287L])238.0 ± 23.80.493 ± 0.07
Docking(α4[G281A, V236A])3(β2[wt])228.1 ± 4.840.998 ± 0.1
Docking(α4[wt])3(β2[I218A,L257A])226.6 ± 3.650.862 ± 0.08
Docking + GABA(α4[G281A, V236A])3(β2[M368W])224.3 ± 5.550.629 ± 0.07
GABA(α4[wt])3(β2[Y275W])221.1 ± 6.750.988 ± 0.1
GABA(α4[wt])3(β2[M368W])21.58 ± 0.5080.493 ± 0.09
MD + GABA(α4[V356W])3(β2[M368W])21.46 ± 0.2191.56 ± 0.3
# 9´Aα5[V9´A](α4[wt]β2[wt])20.818 ± 0.01780.818 ± 0.03
ADNFLE(α4[S10'L])3(β2[wt])20.671 ± 0.1120.512 ± 0.04
MD + GABA(α4[F299W, L376W])3(β2[M368W])20.511 ± 0.02931.39 ± 0.09
MD(α4[F299W])3(β2[wt])20.508 ± 0.03091.20 ± 0.07
MD + GABA(α4[L376W])3(β2[M368W])20.504 ± 0.07111.41 ± 0.2
9´ residue(α4[L9´M])3(β2[wt])20.503 ± 0.06630.585 ± 0.04
MD + GABA(α4[F299W])3(β2[M368W])20.486 ± 0.04341.25 ± 0.1
9´ residue(α4[L9´M])2(β2[wt])30.380 ± 0.03071.22 ± 0.1
MD(α4[V356W])3(β2[wt])20.360 ± 0.01881.65 ± 0.1
9´ residue + GABA(α4[L9´A])3(β2[M368W])20.0230 ± 0.002000.900 ± 0.06
# 9´A(α4[wt])3(β2[L9´A])20.0695 ± 0.003531.32 ± 0.07
9´ residue(α4[L9´T])3(β2[wt])20.0981 ± 0.007290.995 ± 0.06
9´ residue(α4[L9´I])3(β2[wt])2160. ± 50.30.866 ± 0.1
9´ residue(α4[wt])2(β2[L9´A])30.0197 ± 0.001631.12 ± 0.09
9´ residue(α4[L9´A])3(β2[wt])20.0159 ± 0.0006911.16 ± 0.05
9´ residue + MD(α4[L9´A])3(β2[V360W])20.00352 ± 0.0002901.19 ± 0.1
9´ residue + MD(α4[L9´A])3(β2[F328W])20.00318 ± 0.0002371.13 ± 0.08
ACh Binding Site(α4[H116V,Q124F,T126L])3(β2[wt])276.3 ± 1.851.63 ± 0.06
Intra-subunit(α4[C233A])3(β2[wt])2143 ± 17.20.99 ± 0.08
Intra-subunit(α4[T235A])3(β2[wt])243.6 ± 3.891.10 ± 0.09
Intra-subunit(α4[V236A])3(β2[wt])276.2 ± 14.21.31 ± 0.3
Intra-subunit(α4[G281F])3(β2[wt])233.5 ± 9.871.49 ± 0.6
Intra-subunit(α4[S232A])3(β2[wt])2162 ± 20.60.993 ± 0.08
Intra-subunit(α4[G281A])3(β2[wt])219.9 ± 1.471.49 ± 0.2
Near Cys loop(α4[E52L])3(β2[wt])233.3 ± 2.711.27 ± 0.1
Near Cys loop(α4[E182Q])3(β2[wt])263.5 ± 4.541.66 ± 0.2
Near Cys loop(α4[wt])3(β2[S44A])286.1 ± 8.211.70 ± 0.3
Channel pore(α4[L265A])3(β2[wt])226.5 ± 6.580.864 ± 0.2
Channel pore(α4[wt])3(β2[L257A])20.316 ± 0.1011.31 ± 0.4
Interfacial(α4[F286A])3(β2[wt])246.5 ± 8.450.962 ± 0.1
Interfacial(α4[wt])3(β2[I218A])2119 ± 11.71.21 ± 0.1
Interfacial(α4[G281A])3(β2[I218A])223.8 ± 2.280.868 ± 0.5
  • WT-LS, Wild-type α4β2 receptor with the low sensitivity stoichiometry; WT-HS, wild-type α4β2 receptor with the high sensitivity stoichiometry; WT-α5, wild-type α4β2 receptor with α5 in the auxiliary position; 9´ residue, a mutant at the 9´ position to probe the effects of mutations at this site; GABA, analogous site for the menthol binding site in the GABA receptor; MD, molecular dynamics predicted position; TRPM8, analogous site for the menthol binding site on the TRPM8 receptor; ANDFLE, a mutant that is found in ADNFLE patients; Docking, position predicted by preliminary docking studies; #L9´A, mutant made to probe the effects that the number of 9´A mutations has on the effects of menthol; ACh binding site, the putative ACh binding site; Intra-subunit, site between subunits in the transmembrane domain of α4β2; Near Cys loop, site that is near the Cys loop of α4β2; Channel pore, site that is in the channel pore of α4β2; Interfacial, a site on the transmembrane domain of a single subunit that faces toward the other transmembrane domain helices on the same subunit.